6 min. Read

Quest bought Pack Health for $123M cash. Trials

Issue 191

Welcome back to E&O Fridays, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health.

E&O Fridays.

OK, here's what's happening this week in the world of pharma digital

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases

Help me get ahead. $200/year

Newsletters

RIP Caraway Health. Growth metrics: Bicycle, Hone, Oshi, Calibrate, more. Aetna virtual clinics.

1.31.25

8 min. Read

NightWare revenue. Oui terminates trial. 2025 FDA guidance priorities, posteriorities

1.17.25

7 min. Read

Transcarent-Accolade by the numbers. Ribbon pricetag? Pricing intel: Lyra, Teladoc, Included, Wondr

1.10.25

6 min. Read

Included Health’s max payout from CalPERS. Sword Health’s AI vs human pricing.

12.19.24

6 min. Read

NY Medicaid won’t pay for Freespira, CanvasDx. Insolvent Mahana’s first asset sale.

12.13.24

9 min. Read

Final Fee Schedule: How CMS tweaked its digital mental health treatment G-codes

11.01.24

5 min. Read

RIP Marley Medical. 49 virtual clinics Aetna promotes to Amazon employees

10.25.24

8 min. Read

Pricing intel: Kaia, Daybreak, Meru. Walmart adds Twin Health as employee benefit

10.18.24

4 min. Read

CMS prices MedRhythms InTandem. Big Health courts health systems

10.11.24

4 min. Read

Mahana Therapeutics’ insolvency. FDA clears Happy Ring (Tinder founder’s smart ring)

10.04.24

6 min. Read

Quest bought Pack Health for $123M cash. Trials

E&O Fridays.

Paying Subscribers Only

Full access to E&O's research and newsletters.

New! E&O's free weekly newsletter.